Filter
383
Text search:
Chagas
Featured
Recommendations
30
New Publications
58
Language
Document type
No document type
93
Studies & Reports
86
Guidelines
71
Strategic & Response Plan
32
Resource Platforms
29
Fact sheets
28
Manuals
16
Videos
10
Training Material
5
Situation Updates
5
Infographics
5
Dashboards/Maps
2
App
1
Countries / Regions
Global
48
Latin America and the Carribbean
39
Paraguay
15
Argentina
13
Brazil
13
Colombia
13
Venezuela
12
Bolivia
8
India
3
Germany
3
Mexico
3
Africa
3
USA
2
Saudi Arabia
2
Uganda
2
Pakistan
2
Iraq
2
Jordan
2
Lebanon
2
Syria
2
Rwanda
2
Sudan
2
Peru
2
Ecuador
2
El Salvador
2
Chile
2
Iran
2
North America
2
Liberia
1
Senegal
1
Morocco
1
Ghana
1
Somalia
1
Afghanistan
1
Egypt
1
Kenya
1
South Africa
1
Honduras
1
Greece
1
Libya
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Palestine
1
Albania
1
Djibouti
1
Qatar
1
Georgia
1
Uruguay
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
91
Clinical Guidelines
63
Public Health
34
Pharmacy & Technologies
15
Key Resources
9
Women & Child Health
3
Capacity Building
1
Toolboxes
NTDs
178
HIV
23
COVID-19
17
Rapid Response
15
Planetary Health
12
Global Health Education
9
NCDs
7
Zika
5
Caregiver
4
Natural Hazards
3
TB
3
Health Financing Toolbox
3
Ebola
2
Refugee
2
Mental Health
2
AMR
2
Pharmacy
2
Disability
1
Cholera
1
Conflict
1
This review focusses on the interactions between the etiologic agent of Chagas disease, Trypanosoma cruzi, and its triatomine vector. The flagellate mainly colonizes the intestinal tract of the insect. The effect of triatomines on trypanosomes is in
...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this b
...
Chagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood don
...
Datos y cifras
Se calcula que en el mundo hay entre 6 y 7 millones de personas infectadas por el Trypanosoma cruzi, el parásito causante de la enfermedad de Chagas, la mayoría de ellas en América Latina.
La infección por Trypanosoma cruzi se p
...
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal p
...
Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in his honor, just over a century ago. He described the clinical aspects of the disease, characterized by its etiolo
...
Providing information, education and communication for key people involved in Chagas disease control
The Information, education and communication (IEC) activities, with the development of contextualized activities for various actors and scenarios about preventative measures and surveillance tools, are essential to increase awareness, reduce biomedical and psychosocial barriers to accessing diagnosi
...
Microorganisms . 2022 Jul 14;10(7):1427.
Chagas disease (CD) is endemic in about 21 countries of the Americas. The disease has spread to recently Chagas-free regions, mainly due to migration, and c
...
Chagas Disease (CD) affects 6–7 million people worldwide and isrelated topoverty-promo ting conditions. Chronic asymptomatic cases are mostly invisible tohealth systems. Aiming totranslate CD discoveries into education/information practices torais
...
Chagas disease, or American trypanosomiasis, is a condition that causes gradual organ damage. Without treatment, it can be fatal.
This article explains where the T. cruzi parasite is most common and how it can spread. It also outlines the symptom
...
Chagas disease is found mainly in endemic areas of 21 continental Latin American countries. The most common way people are infected with Chagas is through the blood-sucking triatomine bugs, also kno
...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects.
...
Chagas disease affects 8-10 million people worldwide, mainly in Latin America. The current therapy for Chagas disease is limited to nifurtimox and benznidazole, which are effective in treating only
...
First discovered more than 100 years ago, Chagas disease continues to affect more than six million people worldwide and is one of the most prevalent public health problems in Latin America and, increasingly, on a global scale. In the last decades, m
...
Chagas disease is a neglected tropical disease cause by the Trypanosoma cruzi parasite. It is spread mostly by insects known as Triatominae, or kissing bugs.
If left untreated, Chagas can cause se
...
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Chagas disease is increasingly reported in Latin American migrants who have settled in Europe. It has rarely been reported in the UK due to lack of testing an
...
Chagas disease is a zoonosis caused by the protozoa Trypanosoma cruzi. It is transmitted to humans by contact of triatomine bug faeces with a break in the skin (often caused by a bite from the triatomine bug), or with mucous membranes. Transmission
...
Education and information about Chagas Disease, Triatomine bugs, Kissing Bugs, fact sheets, information for special groups, prevention and control, epidemiology, diagnosis and treatment for Health Professionals.
El Chagas se puede prevenir y tratar
Education and information about Chagas Disease epidemiology and risk factors.
